News
Join us for the PharmaEd Combination Product Summit 2023
Join us for the PharmaEd Combination Product Summit 2023 on Wednesday, May 17, at 1:00 pm EST. During the summit, Asmita Khanolkar, Senior Director at SMC, will be presenting “An Integrated Approach to Combination Product Development.” Don’t miss out on this informative presentation! Click here to register now.
Read MoreEnsure Speed and Success with Your Drug Delivery Project: Best Practices for Establishing a Firm Foundation with a Contract Manufacturer – Webinar
Join us for a webinar on Thursday, May 18 at 11:00 a.m. Eastern, where we will be discussing “Ensure Speed and Success with Your Drug Delivery Project: Best Practices for Establishing a Firm Foundation with a Contract Manufacturer.” As drug delivery projects become increasingly complex, it’s more important than ever to have a strong foundation…
Read MoreUri Baruch Named as New Vice President and General Manager of SMC Ltd.’s UK Division
Cambridge, United Kingdom – SMC Ltd., a global medical device and pharmaceutical services company, is proud to announce the appointment of Uri Baruch as the new Vice President and General Manager of its European Division, which includes Oval Medical Technologies and Cambridge Pharma Ltd. (CPL), effective immediately. “Uri’s appointment comes at an important time for…
Read MoreSMC Sponsors StrykerTalks Podcast powered by Device Talks
Listen to the latest StrykerTalks podcast episode, sponsored by SMC Ltd., where CEO Kevin Lobo says he’s seeing the skies clearing a bit for the MedicalDevice industry and hospitals though challenges remain. Earnings are improving, and new ProductInnovation is producing a super-cycle of new products. Listen now to hear Lobo’s perspective on Stryker’s position globally…
Read MoreSMC Ltd. Featured in Springer Nature’s “Journal of Pharmaceutical Sciences.”
Read our latest original research article in Springer Nature “Journal of Pharmaceutical Sciences” by Asmita Khanolkar, Susie White and Elizabeth Margerison titled “A Novel Method to Optimize Drug Delivery for Parenteral Products.” Pharm Res (2023). Read it now
Read MoreSMC Announces Opening of Cambridge Pharma
SMC announces the opening of Cambridge Pharma a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000 sq ft facility located at the Cambridge Research Park, UK, includes a purpose-built sterile fill-finish facility, a process development laboratory and an analytical laboratory. Services include process development and scale up, sterile fill-finish for clinical…
Read MoreSMC Ltd. Announces Expansion for Costa Rica Facility
With continued growth, SMC Ltd. announces expansion of its Costa Rica facility in the Coyol Free Zone Park in Alajuela, Costa Rica. The expansion will double its current facility bringing it to 120,000 square feet in Costa Rica. With the additional space, SMC Costa Rica will provide increased contract manufacturing solutions including: assembly, injection molding…
Read MoreSMC Ltd. Partners to Create Face Shields For First Responders
SMC Ltd. is providing face shields to first responders through a partnership with 3 other companies also donating their services. SMC’s engineering and tooling department designed and built tooling for the face shields in a record 72 hours, then molded the headband frames from resin donated by Eastman. A third company donated the replaceable clear…
Read MoreSMC’s Devens Massachusetts location receives Global Trade Award from AIM (Associated Industries of Massachusetts)
Recognized for its success in Global Medical Device manufacturing excellence, SMC Devens received the Global Trade Award at the AIM annual trade symposium held in November. AIM recognizes Massachusetts leading companies for excellence in global trade. SMC’s Vice President and Massachusetts General Manager, Brian Payson, accepted the award.
Read MoreOval Medical Technologies moves to new location in Cambridge, UK Research Park to support pharmaceutical partners’ advanced drug-delivery needs
Cambridge U.K. – 19 August 2019 Oval Medical Technologies Limited (Oval), a leader of patient-centric autoinjectors, has signalled a new stage in its growth with a move to a purpose-designed facility in Cambridge Research Park, U.K. The new facility provides dedicated GMP labs, enhanced device development, space to house the expanded team, and room for growth…
Read More